Late myocardial ischemic events after saphenous vein graft intervention - Importance of initially 'nonsignificant' vein graft lesions

American Journal of Cardiology

Volumn 79, Issue 11, 1997, Pages 1460-1464

  Ellis, Stephen G ^a   Brener, Sorin J ^a   Deluca, Sue ^a   Tuzcu, E Murat ^a   Raymond, Russell E ^a   Whitlow, Patrick L ^a   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPOCHOLESTEROLEMIC AGENT; NITRATE; WARFARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; SAPHENOUS VEIN GRAFT; SURVIVAL; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; SAPHENOUS VEIN; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030967488     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00171-9     Document Type: Article

References (20)

1. Vital and Health Statistics: Detailed Diagnoses and Procedures National Hospital Discharge Survey, 1991. Series 13: Data from the National Health Survey No. 115. U.S. Department of Health and Human Services, Hyattsville, MD, February, 1994.
2. Campeau L, Lesperance J, Hermann J, Corbara F, Grondin CM, Bourassa MG. Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery. Circulation. 60:((suppl I)):1979;I-1-I-5.
3. Cameron A, Kemp HG, Shimomura S, Santilli E, Green GE, Hutchinson JE, Mekhjian HA. Aortocoronary bypass surgery, a 7-year follow-up. Circulation. 60:((suppl I)):1979;I-9-I-13.
4. Johnson WD, Kayser KL, Pedraza PM. Angina pectoris and coronary bypass surgery. Am Heart J. 100:1984;1190-1197.
5. Ellis SG, Omoigui N, Bittl JA, Lincoff AM, Wolfe MW, Howell G, opol EJ. Analysis of operator specific outcomes in interventional cardiology from a multicenter database of 4860 quality-controlled procedures. Circulation. 93:1996;431-439.
6. Cote G, Myler RK, Stertzer SH, Clark DA, Fishman-Rosen J, Murphy M, Shaw RE. Percutaneous transluminal angioplasty of stenotic coronary artery bypass grafts: 5 years' experience. J Am Coll Cardiol. 9:1987;8-17.
7. Friedrich SP, Davis SF, Kuntz RE, Carrozza JPJ, Baim DS. Investigational use of the Palmaz-Schatz biliary stent in large saphenous vein grafts. Am J Cardiol. 71:1993;439-441.
8. Plokker HWT, Meester BH, Serruys PW. The Dutch experience in percutaneous transluminal angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass. Am J Cardiol. 67:1991;361-366.
9. Piana RN, Moscucci M, Cohen DJ, Kugelmass AD, Senerchia C, Kuntz RE, Baim DS, Carrozza JP. Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. J Am Coll Cardiol. 23:1994;1296-1304.
10. Wong SC, Chuang YC, Popma JJ, Hong MK, Pichard AD, Satler LF, Kent KM, Bucher TA, Donavan K, Morgan K, Leon MB. Comparitive analysis of long term clinical outcomes after native coronary versus saphenous vein graft stent implantation. J Am Coll Cardiol. 25:1995;198A.
11. Sketch MH Jr, Wong SC, Chuang YC, Phillips HR, Heuser R, Savage M, Stack RS, Baim DS, Schatz RA, Leon MB. Progressive deterioration in late (2-year) clinical outcomes after stent implantation in saphenous vein grafts: the Multicenter JJIS experience. J Am Coll Cardiol. 25:1995;79A.
12. Berdan LG, Holmes DR, Keeler G, Califf RM, Topol EJ. High event rate in patients with saphenous vein grafts undergoing percutaneous coronary interventions: CAVEAT II one year follow-up. (abstr). Circulation. 90:((suppl I)):1994;I-63.
13. Kleiman NS, Rodriguez AR, Raizner AE. Interobserver variability in grading of coronary arterial narrowings using the American College of Cardiology/American Heart Association grading criteria. Am J Cardiol. 69:1992;413-415.
14. Alderman EL, Stadius M. The angiographic definitions of the Bypass Angioplasty Revascularization Investigation. Coronary Artery Dis. 3:1992;1189-1207.
15. Wilkinson L. SYSTAT: The system for statistics. 1990;Systat, Inc, Evanston, IL.
16. SAS Institute. SAS/STAT User's Guide, vol. 2. version 6, 4th ed. Cary, NC: SAS Institute, 1989.
17. Ghazzal ZMB, King, III SB, Douglas JS, Weintraub WS. Late angiographic status of coronary angioplasty site which was <50% narrowed 4 to 12 months after successful angioplasty. Am J Cardiol. 73:1994;892-894.
18. White CW, Vanyi J, Das G, Meyer S, Campeau L,Forrester J, Herd JA, Hoogwerf B, Hunninghake D, Goldenberg I, Domanski M,Knatterud G, for the Post CABG Investigators. Can late saphenous vein graftclosure be predicted by quantitative angiographic analysis before theclinical event? J Am Coll Cardiol 1995;321A.
19. Hirshfeld JW, Schwartz JS, Jogo R, MacDonald RG, Goldberg S, Savage MP, Bass TA, Vetrovec G, Cowley M, Taussig AS, Whitworth HB, Margolis JR, Hill JA, Pepine CJ. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol. 18:1991;647-656.
20. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Shimshak TM, Ligon RW, Hartzler GO. Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts. J Am Coll Cardiol. 23:1994;1038-1042.